intricon corp (IIN:NASDAQ GM)
intricon corp (IIN) Snapshot
|
Open
$4.09
|
Previous Close
$4.15
|
|
|
Day High
$4.09
|
Day Low
$3.94
|
|
|
52 Week High
05/31/12 - $6.95
|
52 Week Low
05/1/13 - $3.75
|
|
|
Market Cap
22.8M
|
Average Volume 10 Days
3.2K
|
|
|
EPS TTM
$-0.08
|
Shares Outstanding
5.7M
|
|
|
EX-Date
10/24/01
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
intricon corp (IIN) Related Businessweek News
No Related Businessweek News Foundintricon corp (IIN) Details
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, and manufactures body-worn devices in the United States and internationally. It offers microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and bio-telemetry devices for medical device manufacturers; and solutions for ambulatory cardiac monitoring. The company also provides bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and a family of safety needle products for original equipment manufacturing customers, as well as offers hearing instrument components. In addition, it provides professional audio headset products used for homeland security and emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing instrument components directly to hearing instrument manufacturers and distributors. IntriCon Corporation has a strategic partnership with Advanced Medical Electronics Corp. to develop bio-telemetry devices. The company, formerly known as Selas Corporation of America, was founded in 1930 and is headquartered in Arden Hills, Minnesota.
intricon corp (IIN) Top Compensated Officers
intricon corp (IIN) Key Developments
Intricon Corp. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the period, the company reported net sales of $14,633,000 against $16,524,000 for the same period in the last year. Operating loss was $368,000 against operating income of $519,000 for the same period in the last year. Loss before income taxes was $481,000 against income before income taxes of $277,000 for the same period in the last year. Net loss was $471,000 or $0.08 per basic and diluted share against net income of $243,000 or $0.04 per basic and diluted share for the same period in the last year. The growth was primarily due to increased activity from various large medical customers. The company generated over $450,000 in positive operating cash flow for quarter ended March 31, 2013.
Intricon Corp. announced that they will report Q1, 2013 results at 3:00 PM, Central Standard Time on Apr 22, 2013
Intricon Corp., Q1 2013 Earnings Call, Apr 22, 2013
| Recently Viewed | |||
| IIN:US | $4.00 USD | -0.1499 | |
| Company | Last | Change | |
| No competitor information is available for IIN. | |||
| View Industry Companies | |||
Industry Analysis
IIN
Industry Average
| Valuation | IIN | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.4x |
|
| Price/Book | 1.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.2x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact INTRICON CORP, please visit www.intricon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








